MNTA’s PR on favorable CAFC ruling: http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-cafc-decision-143714364.html An immediate launch of Glatopa (generic Copaxone) should now follow, although the PR doesn’t actually announce the launch.